openPR Logo
Press release

Acne Drugs Market Outlook, Critical Insights, Trends Analysis, Key Players And Forecast To 2033

03-11-2024 05:26 AM CET | Health & Medicine

Press release from: The Business research company

Acne Drugs Market Analysis

Acne Drugs Market Analysis

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Acne Drugs Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The acne drugs market size has grown steadily in recent years. It will grow from $5.84 billion in 2023 to $6.11 billion in 2024 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to increase in acne prevalence, rising population, strong economic growth increase in pharmaceutical expenditure, rise in disposable income and increased healthcare expenditure.

The acne drugs market size is expected to see steady growth in the next few years. It will grow to $7.3 billion in 2028 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to faster economic growth, rise in healthcare expenditure, high potential of emerging economies, increasing teenage population and sedentary lifestyles. Major trends in the forecast period include investing in narrow spectrum antibiotics, development of combination therapies for acne treatment, investing on cannabi*s products consisting cannabi*s oil, investing in partnerships to develop new drugs and using social media to market the acne treatment products.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=2412&type=smp

Market Segmentation:
The acne drugs market covered in this report is segmented -
1) By Type: Inflammatory Acne Drugs, Non-Inflammatory Acne Drugs
2) By Therapeutic Class: Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, Other Therapeutics
3) By End User: Hospitals & Clinics, Pharmacies & Drug Stores, Other End Users

Major Driver - Rising Disposable Income Fuels Growth In The Acne Drug Market
An increase in the disposable income of people is one of the major drivers in the acne drug market. An increase in disposable income is usually due to an improved economy leading to increased wages and salaries and boosting healthcare expenditure. According to the Bureau of Economic Analysis, in July 2023, disposable personal income increased by $7.3 billion. The rise in disposable income and increased expenditure on facial care products is expected to continue, thereby driving the market in the forecast period.

Competitive Landscape:
Major companies operating in the acne drugs market report are Johnson & Johnson, Galderma S.A., Almirall SA, Bausch Health Companies Inc., GlaxoSmithKline, Reckitt Benckiser Group, Mayne Pharma Group Limited, Allergan Plc., Cipher Pharmaceuticals, Sol Gel Advanced Topical Therapy, Pfizer Inc., Novartis AG, Merck & Co. Inc., Amgen Inc., Abbott, AstraZeneca, Eli Lilly and Company, Daiichi Sankyo Company Limited, Sinopharm Group Co. Ltd, Mylan N.V., F. Hoffmann-La Roche Ltd, Bayer AG, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries Ltd., Allergan, Cipla Inc., Zydus Cadila, Otsuka Pharmaceutical Co. Ltd, Shanghai Pharmaceuticals Holding Co. Ltd, Jiangsu Hengrui Medicine, Guangzhou Baiyunshan Pharmaceutical, China Meheco Co Ltd, Huadong Medicine Co. Ltd., Pfizer Inc, Galderma S.A., Amgen Europe B.V., Roche Holding AG, Ranbaxy Laboratories, Stiefel Laboratories, BIOCAD, Zentiva (Sanofi), Gedeon Richter Plc, Polpharma SA Pharmaceutical Works, Egis Group, Dermira Inc., Bausch Health Companies Inc., Estee Lauder Inc., Nimue Skincare International.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report

Top Trend - Acne Drug Market Embraces Combination Therapy For Enhanced Efficacy
Combination therapy is the latest trend in the acne drug market. Combination therapy is the process of combining two drugs with different mechanisms of action, such combinations of medication have better efficacy and adherence when compared with monotherapy (the use of only a single drug by itself). The combination of a topical retinoid drug, which unclogs the pores, along with an antimicrobial drug, which is used to treat an infection is being used to treat acne drugs. Example of combination therapy includes Epiduo, Acanya, Ziana, and Benzamycin produced by Galderma, Allergan, Medicis, and Atrix respectively.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Acne Drugs Market Characteristics
3. Acne Drugs Market Trends And Strategies
4. Acne Drugs Market - Macro Economic Scenario
5. Acne Drugs Market Size And Growth
…..
27. Acne Drugs Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acne Drugs Market Outlook, Critical Insights, Trends Analysis, Key Players And Forecast To 2033 here

News-ID: 3421137 • Views:

More Releases from The Business research company

Multichannel Marketing Hubs Market Size, Share Trends Analysis 2033
Multichannel Marketing Hubs Market Size, Share Trends Analysis 2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Multichannel Marketing Hubs Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $8.76 Bn In 2028
Microgrid Monitoring Market Scope, Demand, Size, Analysis 2024-2033
Microgrid Monitoring Market Scope, Demand, Size, Analysis 2024-2033
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Microgrid Monitoring Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $5.48 Bn In 2028 At
Flexographic Printing Technology Market Size, Demand, Analysis 2024-2033
Flexographic Printing Technology Market Size, Demand, Analysis 2024-2033
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Flexographic Printing Technology Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $3.43 Bn In 2028
Image Processing Systems Market to Reach $37.11 Billion by 2028 at 24.7% CAGR within Forecast Period 2024-2033
Image Processing Systems Market to Reach $37.11 Billion by 2028 at 24.7% CAGR wi …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Image Processing Systems Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $37.11 Bn In 2028

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug